|
Pyroptosis‑Triggering Lipid Nanoparticles for Targeted Immunogenic Cell Death
Pyroptosis‑Triggering Lipid Nanoparticles for Targeted Immunogenic Cell Death (Pyroptosis‑Triggering Lipid Nanoparticle, Tech ID: 23‑014)
Technology Overview: This technology introduces lipid nanoparticle (LNP) formulations engineered to trigger pyroptosis, an immunogenic form of programmed cell death. By delivering payloads that selectively activate...
Published: 2/13/2026
|
Inventor(s): Fengqiao Li, Xiaoyang Xu, William Ho
Keywords(s): Cancer, Combination Therapy, Immuno-oncology, Immunotherapies, Inflammatory Disease Modulation, LNP Manufacturing, Patent Pending, Targeted Drug Delivery
Category(s): Drug Delivery, Excipients & Biopharma Manufacturing
|